SENSEX
NIFTY
GOLD
USD/INR

Weather

image 33    C

Company News

The Economic Times

Company / The Economic Times

details

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is bullish on the companys integrated CRDMO model, strong return ratios and growth prospects, forecasting 18% revenue CAGR through FY29. Key triggers include new commercial molecules and biosimilar launches, while customer concentration and high capex remain key risks.

21 Aug 2026 10:49 am